Central effects of tumor necrosis factor alpha and interleukin-1 alpha on nociceptive thresholds and spontaneous locomotor activity

Neurosci Lett. 1992 Dec 14;148(1-2):76-80. doi: 10.1016/0304-3940(92)90808-k.

Abstract

To extend the knowledge on the central effects of cytokines, we studied the effects of tumor necrosis factor alpha and interleukin-1 alpha on nociceptive thresholds and spontaneous locomotor activity in rats. After central administration, both tumor necrosis factor alpha and interleukin-1 alpha significantly (P < 0.001) increase the nociceptive thresholds as measured by the hot-plate test. Tumor necrosis factor alpha, but not interleukin-1 alpha decreases spontaneous locomotor activity evaluated by the Animex test. The increase in nociceptive thresholds induced by tumor necrosis factor alpha or interleukin-1 alpha is not affected by the opiate receptor antagonist naloxone, or antisera against the endogenous opioids beta-endorphin, met-enkephalin or dynorphin. The analgesic effect of tumor necrosis factor alpha is completely antagonized by anti-IL-1 antibodies. Moreover, the cyclooxygenase inhibitor indomethacin does not antagonize the increase of nociceptive thresholds induced by either cytokine.

MeSH terms

  • Analgesia
  • Animals
  • Cerebral Ventricles / drug effects
  • Cerebral Ventricles / physiology*
  • Cross Reactions
  • Dose-Response Relationship, Drug
  • Injections, Intraventricular
  • Interleukin-1 / administration & dosage
  • Interleukin-1 / pharmacology*
  • Male
  • Motor Activity / drug effects*
  • Pain / physiopathology*
  • Radioimmunoassay
  • Rats
  • Rats, Sprague-Dawley
  • Sensory Thresholds / drug effects
  • Tumor Necrosis Factor-alpha / administration & dosage
  • Tumor Necrosis Factor-alpha / pharmacology*
  • beta-Endorphin / analysis
  • beta-Endorphin / metabolism
  • beta-Lipotropin / analysis
  • beta-Lipotropin / metabolism

Substances

  • Interleukin-1
  • Tumor Necrosis Factor-alpha
  • beta-Endorphin
  • beta-Lipotropin